Pamodi ki é difísil atxa un algen ki ten kankru na kólon?
Kanseru di kólon, tanbê konxedu pa kankru kolorektal, é un duénsa gravi y potensialmenti mortal.
É tirseru tipu di kankru más komun na Mérka y sugundu pamodi kankru é más morti.
Taxa di sobrivivensia di 5 anu pa kankru di sélu é sérka di 65%, má kel-li ta varia di akordu ku stádiu na undi ki diagnostikadu.
Si diagnostikadu sédu, taxa di sobrivivénsia a 5 anu podi ser altu ti 90%, má si kankru spadja pa otus párti di korpu, taxa di sobrivivénsia ta kai ti 111%.
É inportanti repara ma kes taxa di sobrevivénsia é sô un estimativa i rezultadus pode varia.
Si sénpri nu faze izamis di pulmon i nu toma tratamentu kel óra, nu pode ten más xansi di ka panha kel tipu di duénsa li.
Andersen LD, Remington P, Trentham-Dietz A, Reeves M: Assessing a decade of progress in cancer control. Oncologist. 2002, 7 (3): 200-4.
Wang YG, Chen KX, Wu GL, Song FJ: An analysis: colon cancer mortality in Tianjin, China, from 1981 to 2000. World J Gastroenterol. 2005, 11 (6): 895-8.
Tsuji K, Harashima E, Nakagawa Y, Urata G, Shirataka M: Time-lag effect of dietary fiber and fat intake ratio on Japanese colon cancer mortality. Biomed Environ Sci. 1996, 9 (2-3): 223-8.
Kanter MH, Schottinger JE, Joshua A, Slezak JM: Beyond Screening: An Interim Report and Analysis of a Multimodal Initiative to Decrease Colon Cancer Mortality. Jt Comm J Qual Patient Saf. 2022, 48 (8): 388-394.
Tseng CH: Diabetes but not insulin is associated with higher colon cancer mortality. World J Gastroenterol. 2012, 18 (31): 4182-90.
Jacobs EJ, Connell CJ, Patel AV, Chao A, Rodriguez C, Seymour J, McCullough ML, Calle EE, Thun MJ: Multivitamin use and colon cancer mortality in the Cancer Prevention Study II cohort (United States). Cancer Causes Control. 2001, 12 (10): 927-34.
['Diskrison: médiku']
['Es site é sô pa studa i pa da informason.']
['Kes informason li ka debe uzadu pa faze diagnóstiku ô pa kura algun prubléma di saúdi.']
['Pur favor, toma nota ma redi neuronal ki ta jenera respóstas pa perguntas, é spesialmenti inakuradu óras ki ta papiadu di konteúdu numériku. Pur izénplu, nunbru di pesoas diagnostikadu ku un duénsa spesifiku.']
['Sénpri buska konsedju di bu médiku ó otu prestador di kuidadu di saúdi kualifikadu sobri un kondison médiku. Nunka ka bu nega konsedju di médiku profisional ô atrasa na buska-l pamodi algun kuza ki bu lé na es pájina. Si bu atxa ma bu pode ten un imerjénsia médiku, txoma 911 ô bai pa kuartu di imerjénsia más pértu imediatamenti.']
['Diskubri autor']
['Lei di Direitus Umanu Digital di 1998, 17 U.S.C. § 512 (o DMCA) ta dispunibiliza rikursus pa titular di direitus ki ta atxa ma material ki ta parsi na Internet ta viola ses direitus di akordu ku lei di direitus di autor di Stadus Unidus. ']
['Si bu kré, di bon fé, ki kualker kontiudu ô material disponibilizadu na nos site ô servisus ta viola bu direitus di autor, bo (ô bu ajenti) podi manda-nu un avizu ta pidi pa retiradu ô blokia es konteúdu ô material.']
['Nu ten ki manda un mensaji pa email (odja "Contact" pa kel email).']
['Es lei ta iziji ki bu notifikason di alegadu violason di copyright inklui kes siginti informason: (1) un deskripson di obra protejedu pa copyright ki e sujetu di alegadu violason; (2) un deskripson di kel konteúdu alegadu y informason sufisienti pa permiti-nu lokaliza kel konteúdu; (3) informason di kontatu pa bo, inkluindu bu enderesu, númeru di tilifon i enderesu di email; (4) un deklarason di bo ki ten un bon fé ma kel konteúdu di forma reklamadu ka e autorizadu pa donu di copyright, o pa se ajenti, o pa kualker lei; ']
['5. un deklarason di bu senhoriu, asinadu sob pena di perjúriu, ma informason na notifikason é izatu y ma bu ten autoridadi pa pratika kel direitu di autor ki foi violadu;']
['i (6) un asinatura fíziku ô iletróniku di kel algen ki é donu di direitus di autor ô di un algen ki sta autorizadu pa aji na se nómi.']
['Si bu ka da tudu informason, kel informason pode dimora txeu ténpu.']
['Kontaktu di Grupu']
['Pur favor, manda-nu email ku kalker pergunta/sugeston.']
How deadly is colon cancer?
Colon cancer, also known as colorectal cancer, is a serious and potentially deadly disease.
It is the third most common cancer in the United States and the second leading cause of cancer deaths.
The overall 5-year survival rate for colon cancer is approximately 65%, but this varies depending on the stage at which the cancer is diagnosed.
If caught early, the 5-year survival rate can be as high as 90%, but if the cancer has spread to other parts of the body, the survival rate drops to around 111%. Early detection and treatment are crucial for improving the chances of survival.
It is important to note that survival rates are only estimates and individual outcomes may vary.
Regular screening and prompt treatment can significantly reduce the risk of colon cancer becoming deadly.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['Na kel ténpu']
['BioMedLib ta uza konputador automatizadu (algoritmus di aprendizagen di mákina) pa gera pares di pergunta y rasposta.']
['Nu ta kumesa ku 35 milhon di publikason biomédicu di PubMed/Medline. tanbê pájinas di internet di RefinedWeb.']
